Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 54 citing articles:

Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022
Nana Wu, Keven Joyal‐Desmarais, Paula Aver Bretanha Ribeiro, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 5, pp. 439-452
Open Access | Times Cited: 187
Evaluation of Waning of SARS-CoV-2 Vaccine–Induced Immunity
Francesco Menegale, Mattia Manica, Agnese Zardini, et al.
JAMA Network Open (2023) Vol. 6, Iss. 5, pp. e2310650-e2310650
Open Access | Times Cited: 175
The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis
Yuntao Zou, Doudou Huang, Qian Jiang, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 41
Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic
Rontgene Solante, Carlos Álvarez, Erlina Burhan, et al.
Expert Review of Vaccines (2022) Vol. 22, Iss. 1, pp. 1-16
Open Access | Times Cited: 41
Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021–January 2022
Brechje de Gier, Liselotte van Asten, Tjarda M. Boere, et al.
Vaccine (2023) Vol. 41, Iss. 31, pp. 4488-4496
Open Access | Times Cited: 29
Impact of vaccination on the association of COVID-19 with cardiovascular diseases: An OpenSAFELY cohort study
Geneviève Cézard, Rachel Denholm, Rosemary Knight, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Cohort study of cardiovascular safety of different COVID-19 vaccination doses among 46 million adults in England
Samantha Ip, Teri-Louise North, Fatemeh Torabi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study
Michela Antonelli, Rose Penfold, Liane S. Canas, et al.
Journal of Infection (2023) Vol. 87, Iss. 6, pp. 506-515
Open Access | Times Cited: 17
Incidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination: a retrospective cohort study of 16 million people
Kurt Taylor, Sophie V. Eastwood, Venexia Walker, et al.
The Lancet Diabetes & Endocrinology (2024) Vol. 12, Iss. 8, pp. 558-568
Open Access | Times Cited: 6
Understanding the time-driven shifts of vaccine effectiveness against any and severe COVID-19 before and after the surge of Omicron variants within 2.5 years of vaccination: A meta-regression
Marek Petráš, D Janovská, Danuše Lomozová, et al.
International Journal of Infectious Diseases (2024) Vol. 142, pp. 106986-106986
Open Access | Times Cited: 5
Comparative effectiveness of the monovalent XBB.1.5-containing covid-19 mRNA vaccine across three Nordic countries
Niklas Worm Andersson, Emilia Myrup Thiesson, Nicklas Pihlström, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Mechanistic models of humoral kinetics following COVID-19 vaccination
Daniel Stocks, Amy Thomas, Adam Finn, et al.
Journal of The Royal Society Interface (2025) Vol. 22, Iss. 222
Open Access
Comparative effectiveness of two- and three-dose COVID-19 vaccination schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study
Edward P K Parker, Elsie Horne, William Hulme, et al.
The Lancet Regional Health - Europe (2023) Vol. 30, pp. 100636-100636
Open Access | Times Cited: 14
Long-term Real-world Protection Afforded by Third mRNA Doses Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infections, Coronavirus Disease 19-related Emergency Attendances and Hospitalizations Amongst Older Singaporeans During an Omicron XBB Wave
Liang En Wee, Deanette Pang, Calvin J. Chiew, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. 8, pp. 1111-1119
Closed Access | Times Cited: 14
Persistence of SARS‐CoV‐2 infection and viral intra‐ and inter‐host evolution in COVID‐19 hospitalized patients
Grazia Pavia, Angela Quirino, Nadia Marascio, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 6
Open Access | Times Cited: 4
Mapping of Public Approach towards COVID-19 Vaccine for Preparedness and Resilience of Emerging Threats to Facilitate Cross-Country Systematic Roll-Out of Resources
Jaimini Sarkar, Chiradeep Sarkar
(2024)
Open Access | Times Cited: 3
Specific and off-target immune responses following COVID-19 vaccination with ChAdOx1-S and BNT162b2 vaccines—an exploratory sub-study of the BRACE trial
Nicole L. Messina, Susie Germano, Rebecca McElroy, et al.
EBioMedicine (2024) Vol. 103, pp. 105100-105100
Open Access | Times Cited: 3
Effectiveness of mRNA COVID-19 Vaccines as First Booster Doses in England: An Observational Study in OpenSAFELY-TPP
Elsie Horne, William Hulme, Edward P K Parker, et al.
Epidemiology (2024) Vol. 35, Iss. 4, pp. 568-578
Open Access | Times Cited: 2
Comparative effectiveness of monovalent XBB.1.5 containing covid-19 mRNA vaccines in Denmark, Finland, and Sweden: target trial emulation based on registry data
Niklas Worm Andersson, Emilia Myrup Thiesson, Nicklas Pihlström, et al.
BMJ Medicine (2024) Vol. 3, Iss. 1, pp. e001074-e001074
Open Access | Times Cited: 2
Effectiveness of COVID-19 Vaccines over 13 Months Covering the Period of the Emergence of the Omicron Variant in the Swedish Population
Yiyi Xu, Huiqi Li, Brian Kirui, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2074-2074
Open Access | Times Cited: 12
Severe and mild-moderate SARS-CoV-2 vaccinated patients show different frequencies of IFNγ-releasing cells: An exploratory study
Eugenio Garofalo, Flavia Biamonte, Camillo Palmieri, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0281444-e0281444
Open Access | Times Cited: 6
Characteristics of unvaccinated and vaccinated critically ill COVID-19 patients in calabria region (Italy): A retrospective study
Andrea Bruni, Federico Longhini, Sebastiano Macheda, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 10
Diabetes following SARS-CoV-2 infection: Incidence, persistence, and implications of COVID-19 vaccination. A cohort study of fifteen million people
Kurt Taylor, Sophie V. Eastwood, Venexia Walker, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Observational methods for COVID-19 vaccine effectiveness research: an empirical evaluation and target trial emulation
Martí Català, Edward Burn, Trishna Rathod‐Mistry, et al.
International Journal of Epidemiology (2023) Vol. 53, Iss. 1
Open Access | Times Cited: 5
Mechanistic models of humoral kinetics following COVID-19 vaccination
Daniel Stocks, Amy Thomas, Adam Finn, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top